41.87% | % of shares held by all insiders |
29.94% | % of shares held by institutions |
51.50% | % of float held by institutions |
57 | Number of institutions holding shares |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
BVF Inc. | 14,571,236 | 30 Mar 2024 | 14.73% | 56,973,534 |
Avidity Partners Management, LP | 4,470,000 | 30 Mar 2024 | 4.52% | 17,477,700 |
Blackrock Inc. | 2,541,952 | 30 Mar 2024 | 2.57% | 9,939,032 |
Redmile Group, LLC | 2,007,031 | 30 Mar 2024 | 2.03% | 7,847,491 |
Morgan Stanley | 1,383,854 | 30 Mar 2024 | 1.40% | 5,410,869 |
Wells Fargo & Company | 1,119,703 | 30 Mar 2024 | 1.13% | 4,378,038 |
Platinum Investment Management Ltd | 1,095,026 | 30 Mar 2024 | 1.11% | 4,281,551 |
Renaissance Technologies, LLC | 515,779 | 30 Mar 2024 | 0.52% | 2,016,695 |
Assenagon Asset Management S.A. | 439,730 | 29 Jun 2024 | 0.44% | 1,719,344 |
Deutsche Bank Aktiengesellschaft | 253,375 | 30 Mar 2024 | 0.26% | 990,696 |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
Blackrock Funds-Health Sciences Opportunity Portfolio | 1,083,340 | 30 May 2024 | 1.10% | 4,235,859 |
BlackRock Health Sciences Term Trust | 752,390 | 30 Mar 2024 | 0.76% | 2,941,844 |
iShares Biotechnology ETF | 414,758 | 29 Jun 2024 | 0.42% | 1,621,703 |
Blackrock Health Sciences Trust | 78,180 | 30 Mar 2024 | 0.08% | 305,683 |
Fidelity NASDAQ Composite Index Fund | 54,797 | 30 May 2024 | 0.06% | 214,256 |
Pacific Select Fund-Health Sciences Portfolio | 53,150 | 30 Mar 2024 | 0.05% | 207,816 |
Fidelity Select Portfolios - Biotechnology | 27,202 | 30 May 2024 | 0.03% | 106,359 |
DFA U.S. Vector Equity Portfolio | 15,821 | 29 Apr 2024 | 0.02% | 61,860 |
DFA U.S. Micro Cap Series | 10,530 | 29 Apr 2024 | 0.01% | 41,172 |
Invesco ETF Tr II-Invesco NASDAQ Future Gen 200 ETF | 8,443 | 29 Jun 2024 | 0.01% | 33,012 |